Natural evolution of ductus arteriosus with noninterventional conservative management in extremely preterm infants born at 23-28 weeks of gestation
- PMID: 30759169
- PMCID: PMC6374019
- DOI: 10.1371/journal.pone.0212256
Natural evolution of ductus arteriosus with noninterventional conservative management in extremely preterm infants born at 23-28 weeks of gestation
Abstract
This study aimed to determine the natural course of patent ductus arteriosus (PDA) with noninterventional conservative management and whether the presence and/or prolonged duration of hemodynamically significant (HS) PDA increased the risk of mortality and morbidities in extremely preterm (EPT) infants. We retrospectively reviewed the medical records of EPT infants born at 23-28 weeks of gestation (n = 195) from January 2011 to June 2014, when PDA was managed with noninterventional conservative treatment. We stratified infants into three subgroups of 23-24, 25-26, and 27-28 weeks and analyzed the prevalence and natural evolution of HS PDA, defined as ventilator dependency and PDA size ≥2 mm. Multivariate regression analyses determined if the presence and/or prolonged duration of HS PDA increased the risk for mortality and/or morbidities. The overall incidence of HS PDA was 57% (111/195) at the end of the first postnatal week. In subgroup analyses, infants with 23-24 weeks of gestation had the highest incidence (93%, 50/54), with 64% (47/74) for 25-26 weeks and 21% (14/67) for 27-28 weeks. Six (5%) of 111 infants with HS PDA were discharged without ductus closure, 4 had spontaneous PDA closure on follow up, and device closure was performed for 2 infants. In the multivariate analyses, the presence or prolonged duration (per week) of HS PDA was not associated with the risk of mortality and/or morbidities. Spontaneous closure of HS PDA was mostly achieved, even in EPT infants, with a noninterventional conservative approach. In conclusion, our data showed the incidence and natural course of HS PDA in EPT infants and suggested that the presence or prolonged duration of HS PDA might not increase the rate of mortality or morbidities.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures


Similar articles
-
Conservative Management of Patent Ductus Arteriosus Is Feasible in the Peri-Viable Infants at 22-25 Gestational Weeks.Biomedicines. 2022 Dec 28;11(1):78. doi: 10.3390/biomedicines11010078. Biomedicines. 2022. PMID: 36672586 Free PMC article.
-
The effect of hemodynamically significant patent ductus arteriosus on acute kidney injury and systemic hypertension in extremely low gestational age newborns.J Matern Fetal Neonatal Med. 2019 Oct;32(19):3209-3214. doi: 10.1080/14767058.2018.1460349. Epub 2018 Apr 12. J Matern Fetal Neonatal Med. 2019. PMID: 29642731
-
Changes in Serum Creatinine Levels and Natural Evolution of Acute Kidney Injury with Conservative Management of Hemodynamically Significant Patent Ductus Arteriosus in Extremely Preterm Infants at 23-26 Weeks of Gestation.J Clin Med. 2020 Mar 4;9(3):699. doi: 10.3390/jcm9030699. J Clin Med. 2020. PMID: 32143511 Free PMC article.
-
Therapeutic strategy of patent ductus arteriosus in extremely preterm infants.Pediatr Neonatol. 2020 Apr;61(2):133-141. doi: 10.1016/j.pedneo.2019.10.002. Epub 2019 Oct 29. Pediatr Neonatol. 2020. PMID: 31740267 Review.
-
[Transcatheter occlusion of patent ductus arteriosus in a preterm infant and review of literatures].Zhonghua Er Ke Za Zhi. 2016 Jan;54(1):43-6. doi: 10.3760/cma.j.issn.0578-1310.2016.01.010. Zhonghua Er Ke Za Zhi. 2016. PMID: 26791923 Review. Chinese.
Cited by
-
Conservative Management of Patent Ductus Arteriosus in Preterm Infants-A Systematic Review and Meta-Analyses Assessing Differences in Outcome Measures Between Randomized Controlled Trials and Cohort Studies.Front Pediatr. 2021 Feb 25;9:626261. doi: 10.3389/fped.2021.626261. eCollection 2021. Front Pediatr. 2021. PMID: 33718300 Free PMC article.
-
Conservative Management of Patent Ductus Arteriosus Is Feasible in the Peri-Viable Infants at 22-25 Gestational Weeks.Biomedicines. 2022 Dec 28;11(1):78. doi: 10.3390/biomedicines11010078. Biomedicines. 2022. PMID: 36672586 Free PMC article.
-
Measuring gut perfusion and blood flow in neonates using ultrasound Doppler of the superior mesenteric artery: a narrative review.Front Pediatr. 2023 Aug 2;11:1154611. doi: 10.3389/fped.2023.1154611. eCollection 2023. Front Pediatr. 2023. PMID: 37601136 Free PMC article. Review.
-
Improvement of pulmonary edema and respiratory status after transcatheter PDA closure in the smallest and most premature infants.Front Pediatr. 2025 Apr 24;13:1472431. doi: 10.3389/fped.2025.1472431. eCollection 2025. Front Pediatr. 2025. PMID: 40342893 Free PMC article.
-
Prophylaxis of Patent Ductus Arteriosus with Paracetamol in Extremely Low Gestational Age Newborns (ELGANs): A Single-Institution Observational Study in Vietnam.Children (Basel). 2023 Dec 17;10(12):1934. doi: 10.3390/children10121934. Children (Basel). 2023. PMID: 38136136 Free PMC article.
References
-
- Laughon MM, Simmons MA, Bose CL. Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated? Curr Opin Pediatr. 2004; 16:146–51. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources